News
-
-
-
COMMUNIQUÉ DE PRESSE
Secarna Pharmaceuticals establishes Advisory Board with financial markets expert Jens Holstein and shareholder representative Richard Mark Engelhard
Secarna Pharmaceuticals establishes Advisory Board with financial markets expert Jens Holstein and shareholder representative Richard Mark Engelhard to provide strategic guidance and industry expertise -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Secarna Pharmaceuticals and Protalix Biotherapeutics Enter into Collaboration and Option Agreement
Secarna Pharmaceuticals and Protalix Biotherapeutics enter into collaboration and option agreement to develop oligonucleotide therapies for rare renal indications. Combine expertise in rare diseases and biologics -
